The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Karyopharm Therapeutics Inc (NASDAQ: KPTI) closed at $0.77 up 0.46% from its previous closing price of $0.77. In other words, the price has increased by $0.46 from its previous closing price. On the day, 1.04 million shares were traded. KPTI stock price reached its highest trading level at $0.8 during the session, while it also had its lowest trading level at $0.7604.
Ratios:
For a deeper understanding of Karyopharm Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.93 and its Current Ratio is at 3.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on January 19, 2023, initiated with a Overweight rating and assigned the stock a target price of $8.
On November 04, 2022, RBC Capital Mkts Upgraded its rating to Outperform which previously was Sector Perform and also upped its target price recommendation from $7 to $10.
JP Morgan Upgraded its Underweight to Neutral on February 09, 2022, while the target price for the stock was maintained at $8.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 04 ’24 when Paulson Richard A. sold 3,620 shares for $0.81 per share. The transaction valued at 2,932 led to the insider holds 1,128,312 shares of the business.
Paulson Richard A. sold 3,675 shares of KPTI for $3,346 on Nov 05 ’24. The President and CEO now owns 1,131,932 shares after completing the transaction at $0.91 per share. On Oct 04 ’24, another insider, Paulson Richard A., who serves as the President and CEO of the company, sold 3,607 shares for $0.88 each. As a result, the insider received 3,172 and left with 1,135,607 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KPTI now has a Market Capitalization of 96705592 and an Enterprise Value of 230938208. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.63. Its current Enterprise Value per Revenue stands at 1.556 whereas that against EBITDA is -1.838.
Stock Price History:
Over the past 52 weeks, KPTI has reached a high of $1.95, while it has fallen to a 52-week low of $0.62. The 50-Day Moving Average of the stock is -8.91%, while the 200-Day Moving Average is calculated to be -21.84%.
Shares Statistics:
For the past three months, KPTI has traded an average of 794.89K shares per day and 784020 over the past ten days. A total of 125.30M shares are outstanding, with a floating share count of 115.31M. Insiders hold about 8.63% of the company’s shares, while institutions hold 47.15% stake in the company. Shares short for KPTI as of 1731628800 were 18934223 with a Short Ratio of 23.82, compared to 1728950400 on 17614095. Therefore, it implies a Short% of Shares Outstanding of 18934223 and a Short% of Float of 15.409999999999998.
